Rein Therapeutics
$1.21
39
+$0+0% Thursday 20:00
Statistics
Day High
1.33
Day Low
1.11
52W High
2.4
52W Low
1.02
Volume
153,675
Avg. Volume
103,391
Mkt Cap
31.81M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
20MayExpected
Expected EPS
N/A
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-125.77MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow RNTX. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Kura Oncology
KURA
Mkt Cap891.41M
Agios Pharmaceuticals
AGIO
Mkt Cap2.52B
Incyte
INCY
Mkt Cap18.35B
Exelixis
EXEL
Mkt Cap10.41B
Array Technologies
ARRY
Mkt Cap1.32B
Novartis
NVS
Mkt Cap237.61B
About
Rein Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of a novel class of therapeutics for the treatment of cancer and other diseases. It focuses on its lead product candidate, ALRN-6924, which is a cell-permeating peptide that disrupts the interaction of p53 suppressors MDM2 and MDMX with tumor suppressor p53 to reactivate tumor suppression in non-mutant, or wild-type, p53 cancers. The company was founded by Gregory L. Verdine, Rosana Kapeller, Huw M. Nash, Joseph A. Yanchik III, and Loren David Walensky on August 6, 2001 and is headquartered in Austin, TX.
Show more...
CEO
Dr. James Brian Windsor Ph.D.
Employees
11
Country
US
ISIN
US00887A2042
Listings
0 Comments
Share your thoughts
FAQ
What is Rein Therapeutics stock price today?▼
The current price of RNTX is $1.21 USD — it has increased by +0% in the past 24 hours. Watch Rein Therapeutics stock price performance more closely on the chart.
What is Rein Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Rein Therapeutics stocks are traded under the ticker RNTX.
Is Rein Therapeutics stock price growing?▼
RNTX stock has fallen by -3.2% compared to the previous week, the month change is a +0.83% rise, over the last year Rein Therapeutics has showed a -28.82% decrease.
What is Rein Therapeutics market cap?▼
Today Rein Therapeutics has the market capitalization of 31.81M
When is the next Rein Therapeutics earnings date?▼
Rein Therapeutics is going to release the next earnings report on May 20, 2026.
What were Rein Therapeutics earnings last quarter?▼
RNTX earnings for the last quarter are -0.11 USD per share, whereas the estimation was -0.23 USD resulting in a +52.17% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Rein Therapeutics revenue for the last year?▼
Rein Therapeutics revenue for the last year amounts to 0 USD.
What is Rein Therapeutics net income for the last year?▼
RNTX net income for the last year is -125.77M USD.
How many employees does Rein Therapeutics have?▼
As of April 04, 2026, the company has 11 employees.
In which sector is Rein Therapeutics located?▼
Rein Therapeutics operates in the Health Care sector.
When did Rein Therapeutics complete a stock split?▼
The last stock split for Rein Therapeutics was on November 11, 2022 with a ratio of 1:20.
Where is Rein Therapeutics headquartered?▼
Rein Therapeutics is headquartered in Austin, US.